Louis Teitelbaum
Psychiatry · West Islip, NYNPI 1598786956
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $409,236 of the $438,047 with a category attached, or 93.4%. Teva Pharmaceuticals USA, Inc. accounts for 88.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $115,884 and has fallen 69.4% since, to $35,482 in 2025. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 552 payments — averaging $793.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$389K
- Johnson & Johnson$37K
- Alkermes, Inc.$7K
- AbbVie$3K
- Sunovion Pharmaceuticals Inc.$461
- Axsome Therapeutics, Inc.$362
- plus $1K from 15 others
What the payments were for
- Consulting fees$7600%
- Speaking & faculty fees$409,23693%
- Travel & lodging$13,7943%
- Food & beverage$13,9603%
- Education$2970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 395 | $389,234 |
| Johnson & Johnson | 70 | $36,592 |
| Alkermes, Inc. | 16 | $6,773 |
| AbbVie | 7 | $3,143 |
| Sunovion Pharmaceuticals Inc. | 22 | $461 |
| Axsome Therapeutics, Inc. | 3 | $362 |
| Otsuka America Pharmaceutical, Inc. | 5 | $304 |
| Bioxcel Therapeutics, Inc. | 4 | $275 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Lundbeck LLC | 9 | $183 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $139 |
| Progenics Pharmaceuticals, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $76 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Avanir Pharmaceuticals, Inc. | 2 | $30 |
| Shire North American Group Inc | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Indivior Inc. | 1 | $21 |
| Merck | 1 | $18 |
| Chiesi USA, Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$249,575
- Austedo XR$118,495
- SPRAVATO$35,958
- LYBALVI$26,214
- UZEDY$14,697
- VRAYLAR$3,050
- Auvelity$362
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- PYLARIFY$125
- REXULTI$125
- IGALMI$125
- LATUDA$118
- CAPLYTA$105
How this compares
$438,047 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 20 | $2,419 |
| Modafinil | 14 | $1,406 |
| Clozapine | 11 | $986 |
| Clonazepam | 36 | $953 |
| Quetiapine Fumarate | 32 | $504 |
| Olanzapine | 19 | $471 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $444 |
| Duloxetine Hcl | 12 | $353 |
| Escitalopram Oxalate | 32 | $342 |
| Fluoxetine Hcl | 15 | $287 |
| Sertraline Hcl | 15 | $238 |
| Buspirone Hcl | 16 | $202 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 25 | $198 |
| Mirtazapine | 17 | $178 |
| Lamotrigine | 18 | $148 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in West Islip
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.